UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

CUSIP: 917488108

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock
Shares outstanding
3,203,885
Total 13F shares
2,678,889
Share change
-109,332
Total reported value
$222,557,936
Price per share
$83.08
Number of holders
85
Value change
-$9,708,244
Number of buys
42
Number of sells
43

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 917488108?
CUSIP 917488108 identifies UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of UTMD - UTAH MEDICAL PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
15%
478,856
$45,108,000 30 Sep 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
9.1%
291,645
$27,473,000 30 Sep 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
7.8%
250,583
$23,605,000 30 Sep 2018
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
5.6%
180,762
$17,027,000 30 Sep 2018
13F
BlackRock Finance, Inc.
13F
Company
5.6%
180,463
$16,999,000 30 Sep 2018
13F
VANGUARD GROUP INC
13F
Company
5.6%
179,867
$16,944,000 30 Sep 2018
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.4%
173,278
$16,323,000 30 Sep 2018
13F
STATE STREET CORP
13F
Company
3%
96,115
$9,050,000 30 Sep 2018
13F
Ancora Advisors LLC
13F
Company
2.4%
76,621
$7,217,000 30 Sep 2018
13F
Russell Investments Group, Ltd.
13F
Company
1.9%
59,924
$5,644,000 30 Sep 2018
13F
LOOMIS SAYLES & CO L P
13F
Company
1.8%
58,046
$5,468,000 30 Sep 2018
13F
THB ASSET MANAGEMENT
13F
Company
1.8%
58,022
$5,465,000 30 Sep 2018
13F
NORTHERN TRUST CORP
13F
Company
1.8%
56,655
$5,337,000 30 Sep 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
48,285
$4,548,000 30 Sep 2018
13F
Ranger Investment Management, L.P.
13F
Company
1.4%
44,304
$4,173,000 30 Sep 2018
13F
ROYCE & ASSOCIATES LP
13F
Company
1%
33,204
$3,128,000 30 Sep 2018
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.92%
29,350
$2,765,000 30 Sep 2018
13F
Clean Yield Group
13F
Company
0.9%
28,734
$2,707,000 30 Sep 2018
13F
Bank of New York Mellon Corp
13F
Company
0.8%
25,675
$2,419,000 30 Sep 2018
13F
JPMORGAN CHASE & CO
13F
Company
0.78%
25,148
$2,368,000 30 Sep 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.66%
21,289
$2,005,000 30 Sep 2018
13F
Invesco Ltd.
13F
Company
0.63%
20,175
$1,900,000 30 Sep 2018
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.62%
19,900
$1,875,000 30 Sep 2018
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.57%
18,183
$1,709,000 30 Sep 2018
13F
MARTINGALE ASSET MANAGEMENT L P
13F
Company
0.54%
17,302
$1,630,000 30 Sep 2018
13F
NATIXIS ADVISORS, LLC
13F
Company
0.53%
17,080
$1,609,000 30 Sep 2018
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.53%
16,915
$1,593,000 30 Sep 2018
13F
MORGAN STANLEY
13F
Company
0.51%
16,300
$1,536,000 30 Sep 2018
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.5%
16,049
$1,512,000 30 Sep 2018
13F
WEDGE CAPITAL MANAGEMENT L L P/NC
13F
Company
0.47%
14,982
$1,411,000 30 Sep 2018
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.39%
12,541
$1,181,000 30 Sep 2018
13F
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC
13F
Company
0.38%
12,313
$1,160,000 30 Sep 2018
13F
Ativo Capital Management LLC
13F
Company
0.38%
12,025
$1,133,000 30 Sep 2018
13F
ISTHMUS PARTNERS, LLC
13F
Company
0.34%
11,003
$1,036,000 30 Sep 2018
13F
US BANCORP \DE\
13F
Company
0.33%
10,469
$986,000 30 Sep 2018
13F
Cardinal Capital Management
13F
Company
0.31%
9,848
$927,000 30 Sep 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.3%
9,587
$903,000 30 Sep 2018
13F
UBS Group AG
13F
Company
0.25%
8,093
$762,000 30 Sep 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.24%
7,751
$731,000 30 Sep 2018
13F
BESSEMER GROUP INC
13F
Company
0.23%
7,300
$688,000 30 Sep 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.22%
7,028
$662,000 30 Sep 2018
13F
STRS OHIO
13F
Company
0.21%
6,800
$640,000 30 Sep 2018
13F
Allianz Asset Management GmbH
13F
Company
0.19%
5,970
$562,000 30 Sep 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
0.18%
5,894
$555,000 30 Sep 2018
13F
Man Group plc
13F
Company
0.18%
5,689
$536,000 30 Sep 2018
13F
Port Capital LLC
13F
Company
0.17%
5,555
$523,000 30 Sep 2018
13F
Advisory Services Network, LLC
13F
Company
0.17%
5,520
$520,000 30 Sep 2018
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.17%
5,310
$500,000 30 Sep 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.17%
5,292
$499,000 30 Sep 2018
13F
Spark Investment Management LLC
13F
Company
0.16%
5,000
$471,000 30 Sep 2018
13F

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) as of Q4 2018

As of 31 Dec 2018, UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,678,889 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., LAZARD ASSET MANAGEMENT LLC, Vanguard Group Inc, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, LOOMIS SAYLES & CO L P, and THOMSON HORSTMANN & BRYANT INC. This page lists 85 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
89
Q4 2018 holders
85
Holder diff
-4
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 Value $ Q4 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.